相关实验视频

Updated: Jul 1, 2025

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

类固醇对纤维肌痛/染色广泛疼痛患者的影响:一项观察性研究

Obuli Srinivasan Gurunathan¹, Eswaradass Chellapandian², Sibi Thirunavukkarasu³

¹Internal Medicine, Mohan Kumaramangalam Medical College, Salem, IND.

|March 11, 2024

概括

患有甲状腺自身免疫的纤维肌痛患者在类固醇治疗后改善了疼痛管理. 那些强烈阳性抗甲状腺过氧化酶抗体 (抗TPO Ab) 水平的人经历了最大的疼痛减轻.

科学领域:

风湿病学和内分泌学.
疼痛管理疼痛管理
免疫学免疫学免疫学

背景情况:

纤维肌痛的特点是广泛的慢性疼痛,需要有效的疼痛管理策略.
甲状腺自身免疫与纤维肌痛有关,但其对疼痛管理的影响仍未得到充分研究.
研究抗甲状腺过氧化酶抗体 (抗TPO Ab) 阳性在纤维肌痛疼痛中的作用至关重要.

研究的目的:

评估类固醇 (deflazacort) 治疗纤维肌痛患者疼痛的疗效,这些患者的抗甲状腺过氧化酶抗体 (anti-TPO Ab) 阳性水平各不相同.
在基线和3个月随访时使用数值评分表 (NRS) 进行疼痛减轻的比较.

主要方法:

一项回顾性观察性研究包括128名纤维肌痛患者,接受了12毫克德夫拉扎科特治疗.
患者根据抗甲状腺过氧化酶抗体 (抗TPO Ab) 水平进行分类:阴性,阳性和强烈阳性.
疼痛评分 (NRS) 在基线和3个月后跟踪进行了比较,以评估疼痛减轻.

主要成果:

总体而言,51.6%的患者对类固醇治疗有积极反应.
具有阴性或阳性抗TPO Ab水平的患者在疼痛评分下降1分 (p<0.001).
强烈阳性抗TPO Ab组显示,疼痛评分显著降低5分 (p<0.05).

结论:

患有甲状腺自身免疫的纤维肌痛患者对短期类固醇治疗表现出良好的反应.
较高的抗甲状腺过氧化酶抗体 (抗TPO Ab) 阳性水平与纤维肌痛中较大的疼痛缓解相关.
在这种患者小组中,类固醇治疗,特别是德夫拉扎科特,可能是治疗疼痛的有益选择.

关键词:

抗甲状腺过氧化酶抗体的抗甲状腺过氧化酶抗体纤维肌痛是一种纤维肌痛.疼痛管理疼痛管理类固醇类固醇是什么甲状腺自身免疫的发生.

更多相关视频

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

The Effect of Anti-Fatigue Decoction on the Behaviors and Serological Indicators in a Central Fatigue Rat Model

Published on: April 12, 2024

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...